Nihon Lifeline will acquire US-based Cross Vascular and conduct a capital increase. This will result in a change involving a specified subsidiary.
Nihon Lifeline announced that it will acquire US-based Cross Vascular and conduct a capital increase involving an investment in the company.
In connection with the acquisition and capital increase, Nihon Lifeline is expected to make changes to the organisation and capital structure of the specified subsidiary.